Randall A. Ban serves as the Chief Commercial Officer at Inspire Medical Systems Inc., a leading medical technology company focused on developing innovative solutions for patients with obstructive sleep apnea (OSA). In his role, Ban is responsible for overseeing the company's global commercial operations, including sales, marketing, and customer support. His strategic leadership has been instrumental in driving the adoption of Inspire's flagship product, the Inspire therapy system, which offers a unique, implantable solution for OSA patients who cannot tolerate or benefit from traditional CPAP therapy. Prior to joining Inspire Medical Systems, Ban held various senior leadership positions in the medical device industry. He spent over a decade at Medtronic, where he served as Vice President of Sales for the company's Cardiac Rhythm Disease Management division. During his tenure at Medtronic, Ban played a key role in expanding the company's market presence and driving revenue growth through the successful launch of several innovative products. Before Medtronic, he held sales and marketing positions at Boston Scientific and St. Jude Medical, where he developed a deep understanding of the medical device market and honed his skills in commercial strategy and execution. Ban's extensive experience in the medical device industry, coupled with his proven track record of driving commercial success, has been invaluable to Inspire Medical Systems as the company continues to grow and expand its reach. Under his leadership, the company has achieved significant milestones, including the successful launch of the Inspire therapy system in multiple countries and the development of a strong network of healthcare providers trained in the implantation and management of the device. Ban's strategic vision and commitment to improving patient outcomes have positioned Inspire Medical Systems as a leader in the field of sleep medicine and a driving force in the fight against OSA.